Ausgabe 1/2022
Inhalt (163 Artikel)
IL-17 crosses the blood–brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine
Hao Chen, Xueqian Tang, Jin Li, Bangyan Hu, Wenqin Yang, Meng Zhan, Tengyun Ma, Shijun Xu
Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study
Pedro Augusto Sampaio Rocha-Filho, Pedro Mota Albuquerque, Larissa Clementino Leite Sá Carvalho, Mylana Dandara Pereira Gama, João Eudes Magalhães
Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2
Mohammad Mozafarihashjin, Mansoureh Togha, Zeinab Ghorbani, Abolfazl Farbod, Pegah Rafiee, Fahimeh Martami
Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists
G. Krivoshein, E. A. Tolner, AMJM van den Maagdenberg, R. A. Giniatullin
Exploring alterations in sensory pathways in migraine
Noemi Meylakh, Luke A. Henderson
Altered effective connectivity in migraine patients during emotional stimuli: a multi-frequency magnetoencephalography study
Jing Ren, Qun Yao, Minjie Tian, Feng Li, Yueqiu Chen, Qiqi Chen, Jing Xiang, Jingping Shi
Insulin sensitizes neural and vascular TRPV1 receptors in the trigeminovascular system
Judit Rosta, Máté Tóth, Nadine Friedrich, Péter Sántha, Gábor Jancsó, Mária Dux
Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup
Leyi Zhang, Chenglong Lu, Li Kang, Yingji Li, Wenjing Tang, Dengfa Zhao, Shengyuan Yu, Ruozhuo Liu
Alterations in pain processing circuitries in episodic migraine
Tiffani J. Mungoven, Kasia K. Marciszewski, Vaughan G. Macefield, Paul M. Macey, Luke A. Henderson, Noemi Meylakh
Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
Karissa Johnston, Linda Harris, Lauren Powell, Evan Popoff, Vladimir Coric, Gilbert L’Italien, Curtis P. Schreiber
Diagnostic criteria for acute headache attributed to ischemic stroke and for sentinel headache before ischemic stroke
Elena R. Lebedeva, Anton V. Ushenin, Natalia M. Gurary, Denis V. Gilev, Jes Olesen
Efficacy profile of noninvasive vagus nerve stimulation on cortical spreading depression susceptibility and the tissue response in a rat model
Tzu-Ting Liu, Andreia Morais, Tsubasa Takizawa, Inge Mulder, Bruce J. Simon, Shih-Pin Chen, Shuu-Jiun Wang, Cenk Ayata, Jiin-Cherng Yen
Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series
Nijasri C. Suwanwela, Naruchorn Kijpaisalratana, Supatporn Tepmongkol, Wanakorn Rattanawong, Pongpat Vorasayan, Chutibhorn Charnnarong, Jarturon Tantivattana, Sirigunya Roongruang, Tatchaporn Ongphichetmetha, Poonnakarn Panjasriprakarn, Aurauma Chutinet, Wasan Akarathanawat, Jeffrey L. Saver
The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies
Samita Giri, Erling Andreas Tronvik, Knut Hagen
Cortical spreading depression induces propagating activation of the thalamus ventral posteromedial nucleus in awake mice
Xiaoxi Fu, Ming Chen, Jinling Lu, Pengcheng Li
Brain barriers and their potential role in migraine pathophysiology
Astrid Wiggers, Håkan Ashina, Nouchine Hadjikhani, Abhay Sagare, Berislav V. Zlokovic, Martin Lauritzen, Messoud Ashina
Correction to: Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists
G. Krivoshein, E. A. Tolner, A. M. J. M. van den Maagdenberg, R. A. Giniatullin
Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms
Nazia Karsan, Karthik Nagaraj, Peter J. Goadsby
The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
Xinyu Tao, Zeya Yan, Jiahao Meng, Wei Wang, Qiling Dai, Qiufeng Zhou, Zhifeng Wang, Zhong Wang
The applicability research of the diagnostic criteria for 6.7.2 angiography headache in the international classification of headache disorders-3rd edition
Chenglong Lu, Leyi Zhang, Jun Wang, Xiangyu Cao, Xin Jia, Xiaohui Ma, Ran Zhang, Lin Wang, Ying Yang, Fanchao Meng, Shengyuan Yu, Ruozhuo Liu
Dynamic brainstem and somatosensory cortical excitability during migraine cycles
Fu-Jung Hsiao, Wei-Ta Chen, Li-Ling Hope Pan, Hung-Yu Liu, Yen-Feng Wang, Shih-Pin Chen, Kuan-Lin Lai, Gianluca Coppola, Shuu-Jiun Wang
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
Peter McAllister, Paul K. Winner, Jessica Ailani, Dawn C. Buse, Richard B. Lipton, George Chakhava, Mette Krog Josiassen, Annika Lindsten, Lahar Mehta, Anders Ettrup, Roger Cady
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials
Richard B. Lipton, Larry Charleston IV, Cristina Tassorelli, Thomas Brevig, Joe Hirman, Roger Cady
Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients
Takao Takeshima, Masami Nakai, Yoshiyuki Shibasaki, Miki Ishida, Byung-Kun Kim, Xiaoping Ning, Nobuyuki Koga
Sphingosine-1 phosphate receptor 1 contributes to central sensitization in recurrent nitroglycerin-induced chronic migraine model
Qi Pan, Yunfeng Wang, Ruimin Tian, Qianwen Wen, Guangcheng Qin, Dunke Zhang, Lixue Chen, Yixin Zhang, Jiying Zhou
Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors
Jacob C. A. Edvinsson, Aida Maddahi, Isabella M. Christiansen, Philip V. Reducha, Karin Warfvinge, Majid Sheykhzade, Lars Edvinsson, Kristian A. Haanes
Post-traumatic headache after mild traumatic brain injury in a one-year follow up study – risk factors and return to work
Yvonn Kraemer, Kaisa Mäki, Ivan Marinkovic, Taina Nybo, Harri Isokuortti, Antti Huovinen, Antti Korvenoja, Susanna Melkas, Hanna Harno
Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials
Yu-Chen Cheng, Bing-Yan Zeng, Chao-Ming Hung, Kuan-Pin Su, Yi-Cheng Wu, Yu-Kang Tu, Pao-Yen Lin, Brendon Stubbs, Andre F. Carvalho, Chih-Sung Liang, Tien-Yu Chen, Chih-Wei Hsu, Andre R. Brunoni, Mein-Woei Suen, Yow-Ling Shiue, Ping-Tao Tseng, Ming-Kung Wu, Cheng-Ta Li
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
Dawn C. Buse, Paul K. Winner, Larry Charleston IV, Joe Hirman, Roger Cady, Thomas Brevig
Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release
Isabella Mai Christiansen, Jacob C. A. Edvinsson, Philip V. Reducha, Lars Edvinsson, Kristian Agmund Haanes
TIME, to move forward? comment on “a universal outcome measure for headache treatments, care-delivery systems and economic analysis”
Raquel Gil-Gouveia
Correction to: Hyperbaric oxygen attenuates neuropathic pain and reverses inflammatory signaling likely via the Kindlin-1/Wnt-10a signaling pathway in the chronic pain injury model in rats
Baisong Zhao, Yongying Pan, Haiping Xu, Xingrong Song
Time is of the essence in headache measurement. A response to Gil-Gouveia
TJ. Steiner
The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates
Lars Jacob Stovner, Knut Hagen, Mattias Linde, Timothy J. Steiner
Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model
Ruimin Tian, Yun Zhang, Qi Pan, Yunfeng Wang, Qianwen Wen, Xiaoping Fan, Guangcheng Qin, Dunke Zhang, Lixue Chen, Yixin Zhang, Jiying Zhou
Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition
Doga Vuralli, Burak Arslan, Elif Topa, Andreia Lopes de Morais, Ozlem Gulbahar, Cenk Ayata, Hayrunnisa Bolay
Cluster Headache Impact Questionnaire (CHIQ) – a short measure of cluster headache related disability
Katharina Kamm, Andreas Straube, Ruth Ruscheweyh
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, Giorgio Lambru, Anna P. Andreou, Bianca Raffaelli, Astrid Gendolla, Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Sabina Cevoli, Valentina Favoni, Fabrizio Vernieri, Claudia Altamura, Antonio Russo, Marcello Silvestro, Elisabetta Dalla Valle, Andrea Mancioli, Angelo Ranieri, Gennaro Alfieri, Nina Latysheva, Elena Filatova, Jamie Talbot, Shuli Cheng, Dagny Holle, Armin Scheffler, Tomáš Nežádal, Dana Čtrnáctá, Jitka Šípková, Zuzana Matoušová, Alfonsina Casalena, Maurizio Maddestra, Stefano Viola, Giannapia Affaitati, Maria Adele Giamberardino, Francesca Pistoia, Uwe Reuter, Simona Sacco
Genome-wide analysis identified novel susceptible genes of restless legs syndrome in migraineurs
Yun-Jin Jiang, Cathy Shen-Jang Fann, Jong-Ling Fuh, Ming-Yi Chung, Hui-Ying Huang, Kuo-Chang Chu, Yen-Feng Wang, Chia-Lin Hsu, Lung-Sen Kao, Shih-Pin Chen, Shuu-Jiun Wang
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Bianca Raffaelli, Maria Terhart, Jasper Mecklenburg, Lars Neeb, Lucas Hendrik Overeem, Anke Siebert, Maureen Steinicke, Uwe Reuter
Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
Matteo Castaldo, Marta Waliszewska-Prosół, Maria Koutsokera, Micaela Robotti, Marcin Straburzyński, Loukia Apostolakopoulou, Mariarita Capizzi, Oneda Çibuku, Fidel Dominique Festin Ambat, Ilaria Frattale, Zukhra Gadzhieva, Erica Gallo, Anna Gryglas-Dworak, Gleni Halili, Asel Jusupova, Yana Koperskaya, Alo-Rainer Leheste, Maria Laura Manzo, Andrea Marcinnò, Antonio Marino, Petr Mikulenka, Bee Eng Ong, Burcu Polat, Zvonimir Popovic, Eduardo Rivera-Mancilla, Adina Maria Roceanu, Eleonora Rollo, Marina Romozzi, Claudia Ruscitto, Fabrizio Scotto di Clemente, Sebastian Strauss, Valentina Taranta, Maria Terhart, Iryna Tychenko, Simone Vigneri, Blazej Misiak, Paolo Martelletti, Alberto Raggi
FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats
Yanjie Zhou, Lily Zhang, Yuyan Hao, Liu Yang, Shanghua Fan, Zheman Xiao
Abnormalities in resting-state EEG microstates are a vulnerability marker of migraine
Yansong Li, Guoliang Chen, Jing Lv, Lei Hou, Zhao Dong, Rongfei Wang, Min Su, Shengyuan Yu
Attenuated alpha oscillation and hyperresponsiveness reveals impaired perceptual learning in migraineurs
Chun Yuen Fong, Wai Him Crystal Law, Johannes Jacobus Fahrenfort, Jason J. Braithwaite, Ali Mazaheri
Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
Janu Thuraiaiyah, Lili Kokoti, Mohammad Al-Mahdi Al-Karagholi, Messoud Ashina
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d’Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo Filippi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
Maurice T. Driessen, Joshua M. Cohen, Oscar Patterson-Lomba, Stephen F. Thompson, Michael Seminerio, Karen Carr, Todor I. Totev, Rochelle Sun, Erica Yim, Fan Mu, Rajeev Ayyagari
Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-2
Rami Apelian, Lee Boyle, Joe Hirman, Divya Asher
The Global Campaign turns 18: a brief review of its activities and achievements
Timothy J. Steiner, Gretchen L. Birbeck, Rigmor H. Jensen, Paolo Martelletti, Lars Jacob Stovner, Derya Uluduz, Matilde Leonardi, Jes Olesen, Zaza Katsarava
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials
Richard B. Lipton, Rashmi B. Halker Singh, Dennis A. Revicki, Sihui Zhao, Anand R. Shewale, Jordan E. Lateiner, David W. Dodick
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d’Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo Filippi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients
Marina de Tommaso, Marianna La Rocca, Silvia Giovanna Quitadamo, Katia Ricci, Giusy Tancredi, Livio Clemente, Eleonora Gentile, Elena Ammendola, Marianna Delussi
Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database
Alexandre O. Gérard, Diane Merino, Elise K. Van Obberghen, Fanny Rocher, Alexandre Destere, Michel Lantéri-Minet, Milou-Daniel Drici
A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
Lynda J. Krasenbaum, Vasantha L. Pedarla, Stephen F. Thompson, Krishna Tangirala, Joshua M. Cohen, Maurice T. Driessen
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study
Hannah Schenk, Dagny Holle, Michael Nsaka, Christoph Kleinschnitz, Martin Glas, Armin Scheffler
Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
Maurice T. Driessen, Joshua M. Cohen, Stephen F. Thompson, Oscar Patterson-Lomba, Michael J. Seminerio, Karen Carr, Todor I. Totev, Rochelle Sun, Erica Yim, Fan Mu, Rajeev Ayyagari
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Stephanie J. Nahas, Steffen Naegel, Joshua M. Cohen, Xiaoping Ning, Lindsay Janka, Verena Ramirez Campos, Lynda J. Krasenbaum, Dagny Holle-Lee, David Kudrow, Christian Lampl
The economic and personal burden of cluster headache: a controlled cross-sectional study
Anja Sofie Petersen, Nunu Lund, Agneta Snoer, Rigmor Højland Jensen, Mads Barloese
Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor
Sanne Hage La Cour, Kiki Juhler, Lisette J. A. Kogelman, Jes Olesen, Dan Arne Klærke, David Møbjerg Kristensen, Inger Jansen-Olesen
Imaging the inflammatory phenotype in migraine
Rune Häckert Christensen, Cédric Gollion, Faisal Mohammad Amin, Michael A. Moskowitz, Nouchine Hadjikhani, Messoud Ashina
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
Christopher Kjaer Cullum, Thien Phu Do, Messoud Ashina, Lars Bendtsen, Sarah Sonja Hugger, Afrim Iljazi, Julia Gusatovic, Josefin Snellman, Cristina Lopez-Lopez, Håkan Ashina, Faisal Mohammad Amin
Effects of a history of headache and migraine treatment on baseline neurocognitive function in young athletes
Lily McCarthy, Theodore C. Hannah, Adam Y. Li, Alexander J. Schupper, Eugene Hrabarchuk, Roshini Kalagara, Muhammad Ali, Alex Gometz, Mark R. Lovell, Tanvir F. Choudhri
Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis
J.O. Lloyd, B. Hill, M. Murphy, A. Al-Kaisy, A. P. Andreou, G. Lambru
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d’Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo Filippi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
Siu Hing Lo, Katy Gallop, Timothy Smith, Lauren Powell, Karissa Johnston, Lena T. Hubig, Emma Williams, Vladimir Coric, Linda Harris, Gilbert L’Italien, Andrew J. Lloyd
Narrative-based medicine in headache disorders
Christian Lampl, Simona Sacco, Paolo Martelletti
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, Lars Bendtsen, Christina I. Deligianni, Raquel Gil-Gouveia, Zaza Katsarava, Antoinette MaassenVanDenBrink, Paolo Martelletti, Dimos-Dimitrios Mitsikostas, Raffaele Ornello, Uwe Reuter, Margarita Sanchez-del-Rio, Alexandra J. Sinclair, Gisela Terwindt, Derya Uluduz, Jan Versijpt, Christian Lampl
CGRP and PACAP-38 play an important role in diagnosing pediatric migraine
Junhui Liu, Guan Wang, Yuan Dan, Xinjie Liu
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Marcello Silvestro, Alessandro Tessitore, Ilaria Orologio, Rosa De Micco, Lorenzo Tartaglione, Francesca Trojsi, Gioacchino Tedeschi, Antonio Russo
A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
Fumihiko Sakai, Koichi Hirata, Hisaka Igarashi, Takao Takeshima, Takeo Nakayama, Hiromi Sano, Hiroyuki Kondo, Yoshiyuki Shibasaki, Nobuyuki Koga
Repeated inflammatory dural stimulation-induced cephalic allodynia causes alteration of gut microbial composition in rats
Shuai Miao, Wenjing Tang, Heng Li, Bozhi Li, Chunxiao Yang, Wei Xie, Tao Wang, Wenhao Bai, Zihua Gong, Zhao Dong, Shengyuan Yu
Hypoperfusion in nucleus accumbens in chronic migraine using 3D pseudo-continuous arterial spin labeling imaging MRI
Mengqi Liu, Yijie Sun, Xin Li, Zhiye Chen
Contribution of tetrodotoxin-resistant persistent Na+ currents to the excitability of C-type dural afferent neurons in rats
Michiko Nakamura, Il-Sung Jang
The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
Ruth Ruscheweyh, Theresa Klonowski, Gudrun Goßrau, Torsten Kraya, Charly Gaul, Andreas Straube, Tim Patrick Jürgens, Jörg Scheidt, Stefanie Förderreuther
P2X7R/NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine
Yajuan Wang, Zhengming Shan, Lily Zhang, Shanghua Fan, Yanjie Zhou, Luyu Hu, Yue Wang, Weidong Li, Zheman Xiao
Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings
Pepa Polavieja, Mark Belger, Shiva Kumar Venkata, Stefan Wilhelm, Erin Johansson
Burden of tension-type headache in the Middle East and North Africa region, 1990-2019
Saeid Safiri, Ali-Asghar Kolahi, Maryam Noori, Seyed Aria Nejadghaderi, Armin Aslani, Mark J. M. Sullman, Mehdi Farhoudi, Mostafa Araj-Khodaei, Gary S. Collins, Jay S. Kaufman, Kurosh Gharagozli
Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study
Pablo Irimia, David García-Azorín, Mercedes Núñez, Sílvia Díaz-Cerezo, Pepa García de Polavieja, Tommaso Panni, Aram Sicras-Navarro, Antoni Sicras-Mainar, Antonio Ciudad
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Miriam Francavilla, Angelo Reggiani, Natalia Realini, Rita Scarpelli, Daniele Piomelli, Cristina Tassorelli
Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks
Gianluca Coppola, Ilenia Corbelli, Antonio Di Renzo, Andrea Chiappiniello, Pietro Chiarini, Vincenzo Parisi, Giorgio Guercini, Paolo Calabresi, Roberto Tarducci, Paola Sarchielli
Interictal osmophobia is associated with longer migraine disease duration
Gudrun Gossrau, Marie Frost, Anna Klimova, Thea Koch, Rainer Sabatowski, Coralie Mignot, Antje Haehner
Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
Ruth Ruscheweyh, Theresa Klonowski, Gudrun Goßrau, Torsten Kraya, Charly Gaul, Andreas Straube, Tim Patrick Jürgens, Jörg Scheidt, Stefanie Förderreuther
Gamma-aminobutyric acid and glutamate/glutamine levels in the dentate nucleus and periaqueductal gray with episodic and chronic migraine: a proton magnetic resonance spectroscopy study
Wei Wang, Xueyan Zhang, Xiaoyan Bai, Yingkui Zhang, Ziyu Yuan, Hefei Tang, Zhiye Li, Zhangxuan Hu, Yaqing Zhang, Xueying Yu, Binbin Sui, Yonggang Wang
One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey
Thien Phu Do, Simon Stefansen, Mikala Dømgaard, Timothy J. Steiner, Messoud Ashina
De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study
Daniel Gallo, Leire Manrique, Marcos Polanco, Andrés González-Mandly, Eduardo Torres, Enrique Palacio, José Luis Vázquez, Sara Pérez-Pereda, Vicente González-Quintanilla, Jorge Madera, Julio Pascual
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation
Michael Lowe, Lesley Murray, Alok Tyagi, George Gorrie, Sarah Miller, Krishna Dani
Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences
Håkan Ashina, Rune Häckert Christensen, Messoud Ashina
Association between migraine and cognitive impairment
Lihua Gu, Yanjuan Wang, Hao Shu
Gradually shifting clinical phenomics in migraine spectrum: a cross-sectional, multicenter study of 5438 patients
Ye Ran, Ziming Yin, Yajun Lian, Yanmei Xu, Yajie Li, Jiale Liu, Qun Gu, Fanhong Yan, Zhaoli Ge, Yu Lian, Dongmei Hu, Sufen Chen, Yangyang Wang, Xiaolin Wang, Rongfei Wang, Xiaoyan Chen, Jing Liu, Mingjie Zhang, Xun Han, Wei Xie, Zhe Yu, Ya Cao, Yingji Li, Ke Li, Zhao Dong, Shengyuan Yu
Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
Bo Hu, Gang Li, Xiaohong Li, Shan Wu, Tingmin Yu, Xiang Li, Hongru Zhao, Zhihua Jia, Junpeng Zhuang, Shengyuan Yu
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study
Roger Cady, Richard B. Lipton, Dawn C. Buse, Mette Krog Josiassen, Annika Lindsten, Anders Ettrup
Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patients
Ke Li, Shuping Sun, Zhanyou Xue, Sufen Chen, Chunyang Ju, Dongmei Hu, Xiaoyu Gao, Yanhong Wang, Dan Wang, Jianjun Chen, Li Li, Jing Liu, Mingjie Zhang, Zhihua Jia, Xun Han, Huanxian Liu, Mianwang He, Wei Zhao, Zihua Gong, Shuhua Zhang, Xiaoxue Lin, Yingyuan Liu, Shengshu Wang, Shengyuan Yu, Zhao Dong
Long COVID headache
Claudio Tana, Enrico Bentivegna, Soo-Jin Cho, Andrea M. Harriott, David García-Azorín, Alejandro Labastida-Ramirez, Raffaele Ornello, Bianca Raffaelli, Eloísa Rubio Beltrán, Ruth Ruscheweyh, Paolo Martelletti
Correction: Burden of tension-type headache in the Middle East and North Africa region, 1990-2019
Saeid Safiri, Ali-Asghar Kolahi, Maryam Noori, Seyed Aria Nejadghaderi, Armin Aslani, Mark J. M. Sullman, Mehdi Farhoudi, Mostafa Araj-Khodaei, Gary S. Collins, Jay S. Kaufman, Kurosh Gharagozli
Headache-related circuits and high frequencies evaluated by EEG, MRI, PET as potential biomarkers to differentiate chronic and episodic migraine: Evidence from a systematic review
Javier Gomez-Pilar, Víctor Martínez-Cagigal, David García-Azorín, Carlos Gómez, Ángel Guerrero, Roberto Hornero
Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury
Håkan Ashina, Haidar Muhsen Al-Khazali, Afrim Iljazi, Sait Ashina, Faisal Mohammad Amin, Henrik Winther Schytz
Measuring interictal burden among people affected by migraine: a descriptive survey study
Lena T. Hubig, Timothy Smith, Emma Williams, Lauren Powell, Karissa Johnston, Linda Harris, Gilbert L’Italien, Vladimir Coric, Andrew J. Lloyd, Siu Hing Lo
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine
Wei Zhang, Ming Lei, Qianwen Wen, Dunke Zhang, Guangcheng Qin, Jiying Zhou, Lixue Chen
Avoid or seek light – a randomized crossover fMRI study investigating opposing treatment strategies for photophobia in migraine
Eva Matt, Tuna Aslan, Ahmad Amini, Kardelen Sariçiçek, Stefan Seidel, Paul Martin, Christian Wöber, Roland Beisteiner
Applying a biopsychosocial model to migraine: rationale and clinical implications
Chiara Rosignoli, Raffaele Ornello, Agnese Onofri, Valeria Caponnetto, Licia Grazzi, Alberto Raggi, Matilde Leonardi, Simona Sacco
Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case–control study
Rehab Magdy, Alaa Elmazny, Shaimaa H. Soliman, Eman H. Elsebaie, Sara H. Ali, Ali M. Abdel Fattah, Mahmoud Hassan, Ahmed Yassien, Noha A. Mahfouz, Radwa M. Elsayed, Wael Fathy, Hoda M. Abdel-Hamid, Jehan Mohamed, Mona Hussein
HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain
Yu Du, Ceng-Lin Xu, Jie Yu, Keyue Liu, Shi-Da Lin, Ting-Ting Hu, Feng-Hui Qu, Fang Guo, Guo-Dong Lou, Masahiro Nishibori, Wei-Wei Hu, Zhong Chen, Shi-Hong Zhang
Persistent headache after first-ever ischemic stroke: clinical characteristics and factors associated with its development
Elena R. Lebedeva, Anton V. Ushenin, Natalia M. Gurary, Denis V. Gilev, Nadezda V. Kislyak, Jes Olesen
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Christian Lampl, Viktoria Kraus, Katrina Lehner, Brett Loop, Mahan Chehrenama, Zofia Maczynska, Shannon Ritter, Jan Klatt, Josefin Snellman
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis
Xing Wang, Dingke Wen, Qiang He, Chao You, Lu Ma
Insular functional connectivity in migraine with aura
Cédric Gollion, Fleur Lerebours, Federico Nemmi, Germain Arribarat, Fabrice Bonneville, Vincent Larrue, Patrice Péran
Cortical spreading depression can be triggered by sensory stimulation in primed wild type mouse brain: a mechanistic insight to migraine aura generation
Sahin Hanalioglu, Aslihan Taskiran-Sag, Hulya Karatas, Buket Donmez-Demir, Sinem Yilmaz-Ozcan, Emine Eren-Kocak, Yasemin Gursoy-Ozdemir, Turgay Dalkara
Increased risk of all-cause, Alzheimer’s, and vascular dementia in adults with migraine in Korea: a population-based cohort study
Kyungduk Hurh, Sung Hoon Jeong, Seung Hoon Kim, Suk-Yong Jang, Eun-Cheol Park, Sung-In Jang
Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study
Hanna Sobe, Matthias Richter, Reinhard Berner, Maja von der Hagen, Antje Hähner, Ingo Röder, Thea Koch, Rainer Sabatowski, Anna Klimova, Gudrun Gossrau
Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities
Francesca Pistoia, Federico Salfi, Gennaro Saporito, Raffaele Ornello, Ilaria Frattale, Giulia D’Aurizio, Daniela Tempesta, Michele Ferrara, Simona Sacco
Trends in utilization and costs of migraine medications, 2017–2020
Jennifer L. Nguyen, Kiraat Munshi, Samuel K. Peasah, Elizabeth C. S. Swart, Monal Kohli, Rochelle Henderson, Chester B. Good
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
Peter McAllister, Joshua M. Cohen, Verena Ramirez Campos, Xiaoping Ning, Lindsay Janka, Steve Barash
Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress
Timea Aczél, Bettina Benczik, Bence Ágg, Tamás Körtési, Péter Urbán, Witold Bauer, Attila Gyenesei, Bernadett Tuka, János Tajti, Péter Ferdinandy, László Vécsei, Kata Bölcskei, József Kun, Zsuzsanna Helyes
Long term evaluation of a multidisciplinary trigeminal neuralgia service
Sanjeet Singhota, Nana Tchantchaleishvili, Jianhua Wu, Ludvic Zrinzo, Lewis Thorne, Harith Akram, Joanna M. Zakrzewska
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study
Robert P. Cowan, Michael J. Marmura, Hans-Christoph Diener, Amaal J. Starling, Jack Schim, Joe Hirman, Thomas Brevig, Roger Cady
Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications
Chiara Rosignoli, Rafaele Ornello, Agnese Onofri, Valeria Caponnetto, Licia Grazzi, Alberto Raggi, Matilde Leonardi, Simona Sacco
Amplitude of low-frequency fluctuation after a single-trigger pain in patients with classical trigeminal neuralgia
Xiuhong Ge, Luoyu Wang, Lei Pan, Haiqi Ye, Xiaofen Zhu, Sandra Fan, Qi Feng, Wenhua Yu, Zhongxiang Ding
The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study
Nfwama Kawatu, Somwe Wa Somwe, Ornella Ciccone, Misheck Mukanzu, Derya Uluduz, Tayyar Şaşmaz, Bengü Nehir Buğdaycı Yalçın, Christian Wöber, Timothy J. Steiner
Functional connectivity and structural changes of thalamic subregions in episodic migraine
Ying Yang, Huang Xu, Ziru Deng, Wenwen Cheng, Xiuxiu Zhao, Yan Wu, Yuhua Chen, Gui Wei, Ying Liu
Serum CGRP in migraine patients using erenumab as preventive treatment
Simone de Vries Lentsch, Ingrid M. Garrelds, A. H. Jan Danser, Gisela M. Terwindt, Antoinette MaassenVanDenBrink
Preventive treatment can reverse cognitive impairment in chronic migraine
Cristina González-Mingot, Anna Gil-Sánchez, Marc Canudes-Solans, Silvia Peralta-Moncusi, Maria José Solana-Moga, Luis Brieva-Ruiz
A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine
Saval Khanal, Martin Underwood, Seyran Naghdi, Anna Brown, Callum Duncan, Manjit Matharu, Hema Mistry
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
Roberto De Icco, Gloria Vaghi, Marta Allena, Natascia Ghiotto, Elena Guaschino, Daniele Martinelli, Lara Ahmad, Michele Corrado, Federico Bighiani, Federica Tanganelli, Sara Bottiroli, Francescantonio Cammarota, Grazia Sances, Cristina Tassorelli
Development and validation of a novel model for characterizing migraine outcomes within real-world data
Nada A. Hindiyeh, Daniel Riskin, Kimberly Alexander, Roger Cady, Steven Kymes
Synaptic alterations in visual cortex reshape contrast-dependent gamma oscillations and inhibition-excitation ratio in a genetic mouse model of migraine
Nicolò Meneghetti, Chiara Cerri, Eleonora Vannini, Elena Tantillo, Angelita Tottene, Daniela Pietrobon, Matteo Caleo, Alberto Mazzoni
Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors?
Caroline M. Kopruszinski, Robson Vizin, Moe Watanabe, Ashley L. Martinez, Luiz Henrique Moreira de Souza, David W. Dodick, Frank Porreca, Edita Navratilova
Alterations in metabolic flux in migraine and the translational relevance
Olivia Grech, Matilde Sassani, Gisela Terwindt, Gareth G. Lavery, Susan P. Mollan, Alexandra J. Sinclair
A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine
Shouyi Wu, Xiao Ren, Chenlu Zhu, Wei Wang, Kaibo Zhang, Zhilei Li, Xuejiao Liu, Yonggang Wang
Using natural language processing to automatically classify written self-reported narratives by patients with migraine or cluster headache
Nicolas Vandenbussche, Cynthia Van Hee, Véronique Hoste, Koen Paemeleire
Resting-state magnetoencephalographic oscillatory connectivity to identify patients with chronic migraine using machine learning
Fu-Jung Hsiao, Wei-Ta Chen, Li-Ling Hope Pan, Hung-Yu Liu, Yen-Feng Wang, Shih-Pin Chen, Kuan-Lin Lai, Gianluca Coppola, Shuu-Jiun Wang
Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study
Tong Fu, Lindong Liu, Xiaobin Huang, Di Zhang, Yujia Gao, Xindao Yin, Hai Lin, Yongming Dai, Xinying Wu
Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
Heejung Mo, Byung-Kun Kim, Heui-Soo Moon, Soo-Jin Cho
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, Mark Braschinsky, Christina Deligianni, Derya Uludüz, Jan Versijpt, Anne Ducros, Raquel Gil-Gouveia, Zaza Katsarava, Paolo Martelletti, Raffaele Ornello, Bianca Raffaelli, Deirdre M. Boucherie, Patricia Pozo-Rosich, Margarita Sanchez-del-Rio, Alexandra Sinclair, Antoinette Maassen van den Brink, Uwe Reuter
What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials
Yohannes W. Woldeamanuel, Arão B. D. Oliveira
CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury
Håkan Ashina, Afrim Iljazi, Haidar M. Al-Khazali, Thien Phu Do, Anna K. Eigenbrodt, Eigil L. Larsen, Amalie M. Andersen, Kevin J. Hansen, Karoline B. Bräuner, Basit Ali Chaudhry, Casper E. Christensen, Faisal Mohammad Amin, Henrik W. Schytz
Cardiac cephalalgia: a narrative review and ICHD-3 criteria evaluation
María Pilar Navarro-Pérez, Elena Bellosta-Diago, Jes Olesen, Sonia Santos-Lasaosa
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China
Shuhua Zhang, Ya Cao, Fanhong Yan, Sufen Chen, Wei Gui, Dongmei Hu, Huanxian Liu, Hongjin Li, Rongce Yu, Dan Wei, Xiaolin Wang, Rongfei Wang, Xiaoyan Chen, Mingjie Zhang, Ye Ran, Zhihua Jia, Xun Han, Mianwang He, Jing Liu, Shengyuan Yu, Zhao Dong
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, Marco Aguggia, Renata Rao, Maurizio Zucco, Fabio Frediani, Massimo Filippi, Roberta Messina, Sabina Cevoli, Antonio Carnevale, Giulia Fiorentini, Stefano Messina, Francesco Bono, Paola Torelli, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
Anna P. Andreou, Matteo Fuccaro, Bethany Hill, Madeleine Murphy, Valeria Caponnetto, Rachael Kilner, Giorgio Lambru
Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency
Anna K. Eigenbrodt, Rune Häckert Christensen, Håkan Ashina, Afrim Iljazi, Casper Emil Christensen, Timothy J. Steiner, Richard B. Lipton, Messoud Ashina
Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
Marc Ehrlich, Christian Hentschke, Christian Sieder, Monika Maier-Peuschel, Uwe Reuter
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
Andreas R. Gantenbein, Reto Agosti, Christian P. Kamm, Gunther Landmann, Niklaus Meier, Gabriele Susanne Merki-Feld, Jens A. Petersen, Heiko Pohl, Philippe Ryvlin, Christoph J. Schankin, Dragana Viceic, Chiara Zecca, Elisabeth Schäfer, Ina Meyer, Michael E. Arzt
Enhanced pain facilitation rather than impaired pain inhibition in burning mouth syndrome female patients
Christelle Gremeau-Richard, Paul Pionchon, Aurélien Mulliez, Christian Dualé, Radhouane Dallel
Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients
Anne Sofie Schott Andersen, Tone Bruvik Heinskou, Per Rochat, Jacob Bertram Springborg, Navid Noory, Emil Andonov Smilkov, Lars Bendtsen, Stine Maarbjerg
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study
Shengyuan Yu, Byung-Kun Kim, Hebo Wang, Jiying Zhou, Qi Wan, Tingmin Yu, Yajun Lian, Michal Arkuszewski, Laurent Ecochard, Shihua Wen, Fangfang Yin, Zheng Li, Wendy Su, Shuu-Jiun Wang
Genome-wide analyses identify novel risk loci for cluster headache in Han Chinese residing in Taiwan
Shih-Pin Chen, Chia-Lin Hsu, Yen-Feng Wang, Fu-Chi Yang, Ting-Huei Chen, Jia-Hsin Huang, Li-Ling Hope Pan, Jong-Ling Fuh, Hsueh-Chen Chang, Yi-Lun Lee, Hung-Ching Chang, Ko-Han Lee, Yu-Chuan Chang, Cathy Shen-Jang Fann, Shuu-Jiun Wang
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure
Stewart J. Tepper, Jessica Ailani, Sutapa Ray, Joe Hirman, Stephen B. Shrewsbury, Sheena K. Aurora
Tracking the evolution of non-headache symptoms through the migraine attack
Roberta Messina, Ilaria Cetta, Bruno Colombo, Massimo Filippi
Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia
Elina KC, Jaisan Islam, Young Seok Park
Debate: Are cluster headache and migraine distinct headache disorders?
Mohammad Al-Mahdi Al-Karagholi, Kuan-Po Peng, Anja Sofie Petersen, Irene De Boer, Gisela M. Terwindt, Messoud Ashina
Expression of vasopressin and its receptors in migraine-related regions in CNS and the trigeminal system: influence of sex
Aida Maddahi, Lars Edvinsson, Karin Warfvinge
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study
Piero Barbanti, Peter J. Goadsby, Giorgio Lambru, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling
Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study
Ziyu Yuan, Wei Wang, Xueyan Zhang, Xiaoyan Bai, Hefei Tang, Yanliang Mei, Peng Zhang, Dong Qiu, Xue Zhang, Yaqing Zhang, Xueying Yu, Binbin Sui, Yonggang Wang
PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
Song Guo, Charlotte Ernstsen, Anders Hay-Schmidt, David Møbjerg Kristensen, Messoud Ashina, Jes Olesen, Sarah Louise Christensen
Cerebral perfusion variance in new daily persistent headache and chronic migraine: an arterial spin-labeled MR imaging study
Xiaoyan Bai, Wei Wang, Xueyan Zhang, Zhangxuan Hu, Yingkui Zhang, Zhiye Li, Xue Zhang, Ziyu Yuan, Hefei Tang, Yaqing Zhang, Xueying Yu, Peng Zhang, Yonggang Wang, Binbin Sui
CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine
Tse-Ming Chou, Zhung-Fu Lee, Shuu-Jiun Wang, Cheng-Chang Lien, Shih-Pin Chen
The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence
Cedric Gollion, Roberto De Icco, David W. Dodick, Hakan Ashina
Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab
Todd J. Schwedt, Simona Nikolova, Gina Dumkrieger, Jing Li, Teresa Wu, Catherine D. Chong
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting
Ido Peles, Mohnnad Asla, Mariya Abayev, Michal Gordon, Victor Novack, Rinat Ribalov, Tamar Lengil, Ron Maor, Mayera Elizur, Gal Ifergane
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
Andreas R. Gantenbein, Reto Agosti, Christian P. Kamm, Gunther Landmann, Niklaus Meier, Gabriele Susanne Merki-Feld, Jens A. Petersen, Heiko Pohl, Philippe Ryvlin, Christoph J. Schankin, Dragana Viceic, Chiara Zecca, Elisabeth Schäfer, Ina Meyer, Michael E. Arzt
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study
Holly M. Crowe, Amelia K. Wesselink, Lauren A. Wise, Susan S. Jick, Kenneth J. Rothman, Ellen M. Mikkelsen, Henrik T. Sørensen, Elizabeth E. Hatch
Correction: A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
Fumihiko Sakai, Koichi Hirata, Hisaka Igarashi, Takao Takeshima, Takeo Nakayama, Hiromi Sano, Hiroyuki Kondo, Yoshiyuki Shibasaki, Nobuyuki Koga